David Sheff’s new biography convincingly argues for John Lennon’s widow as a feminist, activist, avant-garde artist and world-class sass. By Alexandra Jacobs When you purchase an independently ...

March 20 (Reuters) - Sanofi (SASY.PA), opens new tab on Thursday announced an agreement with biopharmaceutical company Dren Bio for the acquisition of its autoimmune disease treatment DR-0201.

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...

"There was some sniggering" when the news broke that Cherilyn Sarkisian – aka Cher – was going to publish a two-part memoir, said Hadley Freeman in The Sunday Times. While a president can get ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

Biomaterials are those materials — be it natural or synthetic, alive or lifeless, and usually made of multiple components — that interact with biological systems. Biomaterials are often used ...

Boston-based Hill­star Bio on Tues­day be­came the lat­est im­munol­o­gy start­up launch, un­veil­ing a $67 mil­lion Se­ries A round ...

WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical ...

Hillstar Bio is revolutionizing autoimmune disease treatment through a precision-driven approach that selectively depletes pathogenic cells while preserving healthy ones. This method holds the promise ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant.

Apr. 15, 2025 — Researchers have demonstrated a way to use corn protein to improve the performance of lithium-sulfur batteries, a finding that holds promise for expanding the use of the high ...

This would require greater innovation, incentives for scaling-up of bio-based solutions, and the removal of policy and infrastructure bottlenecks. Addressing the regional imbalance would also be ...